Ajanta Pharma Buyback 2024 Latest News Today

May 2, 2024 3:40:12 PM

In an exchange filing, the pharma company informed that it has generated a robust cash flow of Rs 812 crore with an impressive cash conversion ratio of 69 per cent. Given this strong financial ...

May 2, 2024 5:20:00 PM

Ajanta Pharma on Thursday announced a Rs 285 crore buyback of up to 10.28 lakh shares through a tender offer at a price of Rs 2,770 � a premium of 24% --- against Thursdays closing price of Rs 2,233.

May 3, 2024 9:11:48 AM

The Ajanta Pharma stock jumped 13.38 per cent to hit a high of Rs 2,531.95 on BSE. A few target prices on the stock are in the range of Rs 2,560-2,613, suggesting limited upside ahead.

May 5, 2024 2:00:00 PM

Ajanta Pharma Ltd shares gained 8.01% in 1 week after it reported healthy Q4 results and buyback plan. Ajanta Pharma Ltd announced an equity dividend amounting to Rs 51.00 per share in last 1-year, ...

May 2, 2024 5:36:00 PM

The company anticipates the fastest growth to come from its dermatology portfolio, followed by ophthalmology and cardiology.

May 3, 2024 11:06:00 PM

The company will spend Rs 285 crore to carry out the share buyback. The shares of Ajanta Pharma, which has a market cap of Rs 31,087 crore, have given a highest return of around 92 per cent in one ...

May 3, 2024 6:36:00 PM

At 09.21 am, shares of Ajanta Pharma were trading at Rs 2,477.95 on the NSE. The company's board approved its fourth buyback plans in as many years along with its Q4 results. Through the buyback ...

May 3, 2024 10:06:00 AM

Ajanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (YoY) to Rs 203 crore in the March quarter, aided by robust ...

May 3, 2024 9:41:00 AM

Ajanta Pharma recorded a 66 per cent on year spike in consolidated net profit to ?202.72 crore for the January-March period.

May 2, 2024 6:05:00 PM

Ajanta Pharma on Thursday said its consolidated net profit increased 66 per cent to Rs 203 crore in the March quarter, aided by robust sales across domestic and international markets.

May 3, 2024 2:32:00 AM

Ebitda margin came in at 26 per cent. Ajanta Pharma said its board has approved buyback of up to 10,28,881 fully paid-up shares of face value of Rs 2 each by the company, representing 0.82 per ...